Perioperative Nivolumab Improves EFS in Resectable NSCLC ...Middle East

Medscape - News
Interim findings from CheckMate 77T show an overall improvement in event-free survival with perioperative nivolumab vs neoadjuvant nivolumab plus chemotherapy only. Medscape Medical News

Hence then, the article about perioperative nivolumab improves efs in resectable nsclc was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Perioperative Nivolumab Improves EFS in Resectable NSCLC )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News